Event
DPHARM 2025
September 16 - September 17, 2025
Philadelphia, Penn.
DPHARM (Disruptive Innovations to Advance Clinical Research) is the leading event for transforming clinical trials through innovation. Now in its 15th year, the DPHARM®️ Annual Conference brings together over 800 clinical operations professionals, senior executives, and forward-thinking leaders to explore the latest breakthroughs in modernizing clinical research.
This year’s event will challenge the industry to reimagine the future of clinical trials by 2030, featuring real-world examples from organizations already driving change. Attendees will gain valuable insights into how R&D innovation is improving efficiency, accelerating timelines, and ultimately benefiting patients.
Visit Parexel at Booth #200 in the exhibit hall—we’ll be onsite to connect, answer your questions, and discuss how we can support your clinical development needs. Want to ensure time with our team? Schedule a meeting in advance using the link below.
Join several Parexel senior leadership executives on September 16th for a Panel discussion, patient keynote, and an Innovative Sources and solutions track.
Peyton Howell
Chief Executive Officer
September 16 from 8:25 – 8:55 a.m.
Title – Expanding Your Global Footprint for Clinical Research: Readiness to Pivot
Moderator: Janelle Sabo, PharmD, SVP, clinical Research Capabilities, Eli Lilly
Panelists:
- Peyton Howell, CEO, Parexel
- Nikki Amaratunge, VP, Clinical Development Operations, Head of Clinical Site Management, AbbVie
- David Carruthers, VP, Pharmaceutical R&D Clinical Operations, AstraZeneca
- Marta Arias-Salgado, VP, Global Head GCTO Regions and Regional Operations, Merck & Co., Inc.
Keri Mattox
Chief Business Officer
Tuesday, September 16 from 12:15 – 12:25p.m.
Title – AI and Other Trends Impacting Clinical Research Workforce Development
Parexel’s survey of 500 senior leaders and frontline workers at pharmaceutical, biotech and CRO companies benchmarked trends affecting the clinical research labor force. This session will review key survey findings from Optimizing the Clinical Research Workforce, A Parexel Industry Analysis, as well as actionable steps that industry can take to develop strong human capital, positive culture, and talent delivery models to meet the workforce needs of today and the near future.
Charlotte Moser, M.D., Ph.D., M.B.A.
Chief Medical Officer
September 16 from 8:05 – 8:25 a.m.
Title – Patient Keynote
As patient advocate and the first CRISPR Gene Therapy recipient for Sickle Cell Anemia, Victoria Gray will share her incredible story of battling the disease and the life-changing impact of CRISPR therapy.
Speakers:
- Charlotte Moser, MD, PhD, MBA, Chief Medical Officer, Parexel (moderator)
- Victoria Gray, Advocate and First CRISPR Gene Therapy Recipient for SCD at NA
Request a meeting
Are you interested in meeting with our experts at this event? Please fill out the form below, and we'll contact you with more details.